Podcast Episodes

Back to Search
Episode 198: The RADICALS trial in prostate cancer
Episode 198: The RADICALS trial in prostate cancer

Silke Gillessen and Nick James discuss the results of this randomised trial exploring duration of adjuvant/salvage androgen ablation with XRT in pros…

4 years ago

Short Long
View Episode
Episode 197: The Uromigos Nashville 2022
Episode 197: The Uromigos Nashville 2022

Season 1 Episode 197

Here are the details for the Livestream portions of The Uromigos Nashville meeting! 

Bladder Cancel Panel on September 30, 1-2PM CST https://youtu.be…

4 years, 1 month ago

Short Long
View Episode
Episode 196: The COSMIC-313 Trial cabo/ipi/nivo in 1st line renal cancer
Episode 196: The COSMIC-313 Trial cabo/ipi/nivo in 1st line renal cancer

Season 1 Episode 196

Toni Choueiri describes the study. 

4 years, 1 month ago

Short Long
View Episode
Episode 195 ESMO 2022: EV Pembrolizumab in 1st line bladder cancer
Episode 195 ESMO 2022: EV Pembrolizumab in 1st line bladder cancer

Peter O'Donnell describes the study.

4 years, 1 month ago

Short Long
View Episode
Episode 194 ESMO 2022: Pegylated il-2 + nivolumab in renal cancer
Episode 194 ESMO 2022: Pegylated il-2 + nivolumab in renal cancer

Season 1 Episode 194

Nizar Tannir describes this randomised phase 3 study presented at ESMO.

4 years, 1 month ago

Short Long
View Episode
Episode 193 ESMO 2022: PRESTO - a phase III trial of androgen annihilation in biochemically relapsed prostate cancer
Episode 193 ESMO 2022: PRESTO - a phase III trial of androgen annihilation in biochemically relapsed prostate cancer

Season 1 Episode 193

Rahul Aggarwal describes the results of this randomised phase III study.

4 years, 1 month ago

Short Long
View Episode
Episode 192 ESMO 2022: Summary of ESMO Adjuvant RCC Trials
Episode 192 ESMO 2022: Summary of ESMO Adjuvant RCC Trials

Season 1 Episode 192

Axel Bex summarises the ipi/nivo, pembro and atezo studies.

4 years, 1 month ago

Short Long
View Episode
Episode 191 ESMO 2022: PROSPER study of neoadjuvant nivolumab in RCC
Episode 191 ESMO 2022: PROSPER study of neoadjuvant nivolumab in RCC

Season 1 Episode 191

Mohamed Allaf describes the results of this study from ESMO.

4 years, 1 month ago

Short Long
View Episode
Episode 190: ESMO 2022 Preview
Episode 190: ESMO 2022 Preview

Season 1 Episode 190

Chris Sweeney joins us to talk about potential highlights.

4 years, 2 months ago

Short Long
View Episode
Episode 189: The Uromigos Paper of the Month - Robotic vs open cystectomy
Episode 189: The Uromigos Paper of the Month - Robotic vs open cystectomy

Season 1 Episode 189

John Kelly describes the benefits of robotic surgery.

4 years, 2 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us